Related Experiment Video
Updated: Aug 7, 2026
Left Lung Orthotopic Transplantation in a Juvenile Porcine Model for ESLP
Published on: February 14, 2022
Pediatric lung transplantation
1Washington University School of Medicine, St. Louis Children's Hospital, St. Louis, Missouri 63110, USA. huddlestonc@wustl.edu
Insights
Pediatric lung transplantation offers a vital survival option for children with severe lung diseases like cystic fibrosis. However, long-term survival remains around 50% due to complications such as bronchiolitis obliterans and infections.
Area of Science:
- Pediatric surgery
- Pulmonology
- Transplant medicine
Background:
- Lung transplantation in children has been performed since the early 1990s.
- Indications include cystic fibrosis, pulmonary vascular disease, and other fatal pediatric pulmonary conditions.
- Specific conditions involve metabolic abnormalities causing severe respiratory insufficiency in newborns.
Purpose of the Study:
- To review the outcomes and challenges of pediatric lung transplantation.
- To highlight the critical role of transplantation in life-threatening pediatric lung diseases.
- To identify major causes of mortality and potential future improvements.
Main Methods:
- Review of clinical data and outcomes for pediatric lung transplant recipients.
- Analysis of indications for transplantation.
- Identification of post-transplant complications and mortality causes.
Main Results:
- Pediatric lung transplantation provides a last resort for survival in many cases.
- Long-term survival rates are approximately 50% at 5 years.
- Major late mortality causes include bronchiolitis obliterans, infections, and malignancy.
Conclusions:
- Despite significant challenges, lung transplantation remains a crucial option for pediatric patients with end-stage lung disease.
- Improving immunosuppression strategies and managing post-transplant complications are key to enhancing long-term outcomes.
- Further research into novel immunosuppressants may improve survival rates in the future.
Abstract:
Lung transplantation in children has been performed since the early 1990s. The indications are cystic fibrosis, pulmonary vascular disease, and a variety of other pulmonary problems leading to death in small children. These other diseases include abnormalities in the metabolism of surfactant producing severe respiratory insufficiency in newborn infants. Many problems accompany these patients before transplantation and many problems are produced both by the transplant itself and immunosuppressant drugs which these children are obliged to take following transplantation. Nonetheless, lung transplantation offers the only real hope of survival in many instances. The long-term results have been somewhat discouraging with a 5-year survival of approximately 50%. The major causes of mortality late following lung transplantation are bronchiolitis obliterans, infections, and malignancy. The development of newer immunosuppressant drugs may offer hope for better results in the future.
